Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (8)

2022

  1. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity

    Cancers, Vol. 14, Núm. 19

2010

  1. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice

    Hepatology, Vol. 52, Núm. 6, pp. 2096-2108

  2. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes

    Hepatology, Vol. 51, Núm. 6, pp. 2152-2161

2009

  1. S-Adenosylmethionine Regulates Apurinic/Apyrimidinic Endonuclease 1 Stability: Implication in Hepatocarcinogenesis

    Gastroenterology, Vol. 136, Núm. 3, pp. 1025-1036

2008

  1. Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice

    Laboratory Investigation, Vol. 88, Núm. 10, pp. 1121-1129

  2. Expression Pattern, Regulation, and Functions of Methionine Adenosyltransferase 2β Splicing Variants in Hepatoma Cells

    Gastroenterology, Vol. 134, Núm. 1, pp. 281-291

  3. Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2β

    Hepatology, Vol. 47, Núm. 2, pp. 521-531

  4. S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation

    Hepatology, Vol. 47, Núm. 5, pp. 1655-1666